A carregar...
Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab
Bone marrow transplantation (BMT) was introduced as a treatment option 15 years ago for severe, drug-resistant multiple sclerosis (MS). Up until now, BMT has been undertaken in relatively few patients worldwide, with moderate success, and recent studies suggest that patients with early, highly aggre...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2962327/ https://ncbi.nlm.nih.gov/pubmed/21042570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S13648 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|